Abstract
Hematopoietic stem cell transplantation (HSCT) offers a potentially curative treatment for children with advanced hematologic and some non-hematologic malignancies. Since the risk for severe toxicity, treatment-related death, or significant long-term sequelae still substantially exceeds the risks of conventional cancer therapy, HSCT is only considered after relapse or in high-risk cases. Pediatric HSCT patients and their families often face a high burden of symptoms and suffering throughout the immediate course of the transplant and sometimes for years thereafter. Palliative care can introduce aspects of quality of life into the transplant procedure to reduce suffering and support families to cope with long-term sequelae and therapy failure. Specialized pediatric palliative care services could provide much needed additional support during the inpatient phase of the transplant, bridge the gap to the home care setting, assist in care coordination, and take care of the physical, emotional, and spiritual suffering of the patient and the family. Furthermore, palliative care counseling may be helpful in facilitating goals-of-care discussions and advance care planning before HSCT and during the posttransplant phase. Although therapy-related mortality has considerably decreased in the last two decades, a significant number of pediatric HSCT recipients still die due to relapse, acute treatment-related complications, or progressing chronic conditions. In these children, integration of pediatric palliative care can facilitate end-of-life communication and reduce unwarranted interventions such as intubation or cardiopulmonary resuscitation close to the end of life.
References
Armenian SH, Sun C-L, Kawashima T et al (2011) Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 118(5):1413–1420. https://doi.org/10.1182/blood-2011-01-331835
Bader P, Kreyenberg H, von Stackelberg A et al (2015) Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial. J Clin Oncol 33(11):1275–1284. https://doi.org/10.1200/JCO.2014.58.4631
Bitan M, He W, Zhang MJ et al (2014) Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Blood 123(10):1615–1620. https://doi.org/10.1182/blood-2013-10-535716
Bomken S, Skinner R (2015) Secondary malignant neoplasms following haematopoietic stem cell transplantation in childhood. Children 2:146–173. https://doi.org/10.3390/children2020146
Bradshaw G, Hinds PS, Lensing S, Gattuso JS, Razzouk BI (2005) Cancer-related deaths in children and adolescents. J Palliat Med 8(1):86–95. https://doi.org/10.1089/jpm.2005.8.86
Caruso Brown AE, Cohen MN, Tong S et al (2015) Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother 59(7):3718–3725. https://doi.org/10.1128/AAC.04348-14
Choi DK, Helenowski I, Hijiya N (2014) Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature. Int J Cancer 135(8):1764–1773
Chow EJ, Anderson L, Baker KS et al (2016) Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a children’s oncology group report. Blood Marrow Transplant 22(5):7827–7895. https://doi.org/10.1016/j.bbmt.2016.01.023
Cohen J, Cooper N, Chakrabarti S et al (2007) EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning. Leuk Lymphoma 48:256–269. https://doi.org/10.1080/10428190601059837
Collins JJ, Geake J, Grier HE (1996) Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. J Pediatr 129(5):722–728
Conter V, Valsecchi MG, Parasole R et al (2014) Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. Blood 123(10):1470–1478. https://doi.org/10.1182/blood-2013-10-532598
Danner-Koptik KE, Majhail NS, Brazauskas R et al (2013) Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant 48(3):363–368. https://doi.org/10.1038/bmt.2012.166
Deeg HJ, Socié G, Schoch G et al (1996) Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87(1):386–392
Didsbury MS, Mackie FE, Kennedy SE (2015) A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients. Pediatr Transplant 19(5):460–470. https://doi.org/10.1111/petr.12483
Dietrich-Ntoukas T, Cursiefen C, Westekemper H et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the Germn-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 31(3):299–310
El-Jawahri A, LeBlanc T, Van Dusen H et al (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316(20):2094–2103. https://doi.org/10.1001/jama.2016.16786
Federmann B, Hägele M, Pfeiffer M et al (2011) Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts. Leukemia 25(1):121–129. https://doi.org/10.1038/leu.2010.235
Fernández-García M, Gonzalez-Vicent M, Mastro-Martinez I et al (2015) Intensive care unit admissions among children after hematopoietic stem cell transplantation: incidence, outcome, and prognostic factors. J Pediatr Hematol Oncol 37(7):529–535. https://doi.org/10.1097/MPH.0000000000000401
Feudtner C, Womer J, Augustin R et al (2013) Pediatric palliative care programs in children's hospitals: a cross-sectional national survey. Pediatrics 132(6):1063–1070. https://doi.org/10.1542/peds.2013-1286
Fiuza-Luces C, Garatachea N, Simpson RJ et al (2015) Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients. Exerc Immunol Rev 21:80–112
Forinder U, Norberg AL (2014) Posttraumatic growth and support among parents whose children have survived stem cell transplantation. J Child Health Care 18(4):326–335. https://doi.org/10.1177/1367493513496666
Gale RP, Horowitz MM, Ash RC et al (1994) Identical twin bone marrow transplants for leukemia. Ann Intern Med 120:646–652
Groh G, Borasio GD, Nickolay C et al (2013) Specialized pediatric palliative home care: a prospective evaluation. J Palliat Med 16(12):1588–1594. https://doi.org/10.1089/jpm.2013.0129
Gurney JG, Ness KK, Rosenthal J et al (2006) Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the bone marrow transplant survivor study. Cancer 106(6):1402–1408
Hildebrandt GC, Fazekas T, Lawitschka A et al (2011) Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 46:1283–1295
Hutt D, Nehari M, Munitz-Shenkar D et al (2015) Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents. Bone Marrow Transplant 50:1337–1342
Jobe-Shields L, Alderfer MA, Barrera M et al (2009) Parental depression and family environment predict distress in children before stem cell transplantation. J Dev Behav Pediatr 30(2):140–146. https://doi.org/10.1097/DBP.0b013e3181976a59
Kazak AE, Simms S, Alderfer MA et al (2005) Feasibility and preliminary outcomes from a pilot study of a brief psychological intervention for families of children newly diagnosed with cancer. J Pediatr Psychol 30:644–655
Kazak AE, Rourke MT, Alderfer MA et al (2007) Evidenced-based assessment, intervention, and psychosocial care in pediatric oncology: a blueprint for comprehensive services across treatment. J Pediatr Psychol 32:1099–1110
Kolb HJ, Mittermüller J, Clemm C et al (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462–2465
Lafond DA, Kelly KP, Hinds PS, Sill A, Michael M (2015) Establishing feasibility of early palliative care consultation in pediatric hematopoietic stem cell transplantation. J Pediatr Oncol Nurs 32(5):265–277. https://doi.org/10.1177/1043454214563411
Lawitschka A, Güclü ED, Varni JW et al (2014) Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL stem cell transplant module and results of a pilot study. Bone Marrow Transplant 49:1093–1097
Lee SJ (2017) Classification systems for chronic graft-versus-host disease. Blood 129(1):30–37
Lee KH, Lee JH, Lee JH et al (2011) Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome. Blood 118(9):2609–2617. https://doi.org/10.1182/blood-2011-02-339838
Lee SJ, Wolff D, Kitko C (2015) Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biol Blood Marrow Transplant 21:984–999
Llaurador G, McLaughlin L, Wistinghausen B (2016) Management of post-transplant lymphoproliferative disorders. Curr Opin Pediatr 29(1):34–40
Loggers ET, Lee S, Chilson K et al (2014) Advance care planning among hematopoietic cell transplant patients and bereaved caregivers. Bone Marrow Transplant 49(10):1317–1322. https://doi.org/10.1038/bmt.2014.152
Lotz JD, Daxer M, Jox RJ, Borasio GD, Führer M (2017) “Hope for the best, prepare for the worst”: A qualitative interview study on parents’ needs and fears in pediatric advance care planning. Palliat Med 31(8):764–771
Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC (2006) Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24(33):5265–5270
Mack JW, Cook EF, Wolfe J et al (2007) Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol 25(11):1357–1362
Mack JW, Wolfe J, Cook EF et al (2009) Peace of mind and sense of purpose as core existential issues among parents of children with cancer. Arch Pediatr Adolesc Med 163(6):519–524. https://doi.org/10.1001/archpediatrics
MacLeod KD, Whitsett SF, Mash EJ et al (2003) Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell transplants (HSCT): a qualitative study of their psychosocial experience. J Pediatr Psychol 28(4):223–231
Mahmood LA, Casey D, Dolan JG, Dozier AM, Korones DN (2016) Feasibility of early palliative care consultation for children with high-risk malignancies. Pediatr Blood Cancer 63(8):1419–1422. https://doi.org/10.1002/pbc.26024
Manne S, DuHamel K, Ostroff J et al (2004) Anxiety, depressive, and posttraumatic stress disorders among mothers of pediatric survivors of hematopoietic stem cell transplantation. Pediatrics 113:1700–1708
Marks C, Stadler M, Häusermann P et al (2011) German–Austrian–Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Br J Dermatol 165(1):18–29
Maude SL, Teachey DT, Porter DL, Grupp SA (2015) CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood 125(26):4017–4023. https://doi.org/10.1182/blood-2014-12-580068
Meier JK-HH, Wolff D, Pavletic S et al (2011) Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Invest 15:127–139
Meyers CA, Weitzner M, Byrne K, Valentine A et al (1994) Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 12:820–826
Mohty M, Malard F, Abecassis M et al (2015) Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 50(6):781–789. https://doi.org/10.1038/bmt.2015.52
Nelson AS, Ashton LJ, Vajdic CM (2015) Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy. Leukemia 29(2):441–447. https://doi.org/10.1038/leu.2014.203
Ness KK, Bhatia S, Baker KS et al (2005) Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study. Arch Pediatr Adolesc Med 159(8):706–713
Packman W, Weber S, Wallace J, Bugescu N (2010) Psychological effects of hematopoietic SCT on pediatric patients, siblings and parents: a review. Bone Marrow Transplant 45:1134–1146
Pession A, Masetti R, Rizzari C et al (2013) Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. Blood 122(2):170–178. https://doi.org/10.1182/blood-2013-03-491621
Petersen SL (2007) Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Dan Med Bull 54(2):112–139
Phipps S, Mulhern R (1995) Family cohesion and expressiveness promote resilience to the stress of pediatric bone marrow transplant: a preliminary report. J Dev Behav Pediatr 16:257–263
Pillay B, Lee SJ, Katona L et al (2012) The psychosocial impact of haematopoietic SCT on sibling donors. Bone Marrow Transplant 47:1361–1365
Pochon C, Oger E, Michel G et al (2015) Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react. Br J Haematol 169(2):249–261. https://doi.org/10.1111/bjh.13272
Rettinger E, Merker M, Salzmann-Manrique E et al (2017) Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant 23(1):87–95. https://doi.org/10.1016/j.bbmt.2016.10.006. Epub 2016 Oct 11
Richardson PG, Riches ML, Kernan NA et al (2016) Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 127(13):1656–1665. https://doi.org/10.1182/blood-2015-10-676924
Ringden O, Pavletic SZ, Anasetti C et al (2009) The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 113(13):3110–3118
Roeland E, Mitchell W, Elia G et al (2010a) Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: physical symptoms. J Support Oncol 8(3):100–116. Review
Roeland E, Mitchell W, Elia G et al (2010b) Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 2: psychosocial concerns. J Support Oncol 8(4):179–183. Review
Siden H, Chavoshi N, Harvey B et al (2014) Characteristics of a pediatric hospice palliative are program over 15 years. Pediatrics 134(3):e765–e772. https://doi.org/10.1542/peds.2014-0381
Slavin S, Nagler A, Naparstek E (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91(3):756–763
Stuber M, Nader K, Yasuda P (1991) Stress responses after pediatric bone marrow transplantation: preliminary results of a prospective longitudinal study. J Am Acad Child Adoles Psychiatr 30:952–957
Styczynski J, van der Velden W, Fox CP et al (2016) Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation (EBMT-IDWP), the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) Haematologica 101(7):803-811. doi: https://doi.org/10.3324/haematol.2016.144428. Review
Suttorp M, Claviez A, Bader P et al (2009) Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I. Klin Padiatr 221(6):351–357. https://doi.org/10.1055/s-0029-123952
Svenberg P, Remberger M, Uzunel M et al (2016) Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation––a comparison of the last two decades. Pediatr Transplant 20(5):667–674. https://doi.org/10.1111/petr.12723
Terrin N, Rodday AM, Tighiouart H et al (2013) Parental emotional functioning declines with occurrence of clinical complications in pediatric hematopoietic stem cell transplant. Support Care Cancer 21(3):687–695
Ullrich CK, Dussel V, Hilden JM et al (2010) End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care. Blood 115(19):3879–3885
Ullrich CK, Rodday AM, Bingen K et al (2016a) Parent outlook: how parents view the road ahead as they embark on hematopoietic stem cell transplantation for their child. Biol Blood Marrow Transplant 22(1):104–111. https://doi.org/10.1016/j.bbmt.2015.08.040
Ullrich CK, Lehmann L, London WB et al (2016b) End-of-life care patterns associated with pediatric palliative care among children who underwent hematopoietic stem cell transplant. Biol Blood Marrow Transplant 22(6):1049–1055. https://doi.org/10.1016/j.bbmt.2016.02.012
Vrijmoet-Wiersma CMJ, Egeler RM, Koopman HM et al (2009) Parental stress before, during, and after pediatric stem cell transplantation: a review article. Support Care Cancer 17:1435–1443. https://doi.org/10.1007/s00520-009-0685-4
Weitz M, Strahm B, Meerpohl JJ (2015) Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database Syst Rev 12:CD009898. https://doi.org/10.1002/14651858.CD009898.pub3
Wiener L, Baird K, Crum C et al (2014) Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study. Support Care Cancer 22(2):295–305
Wilhelmsson M, Vatanen A, Borgström B et al (2015) Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up. Bone Marrow Transplant 50(6):850–857. https://doi.org/10.1038/bmt.2015.43
Wilkins KL, Woodgate RL (2007a) An interruption in family life: siblings’ lived experience as they transition through the pediatric bone marrow transplant trajectory. Oncol Nurs Forum 34:E28–E35
Wilkins KL, Woodgate RL (2007b) Supporting siblings through the pediatric bone marrow transplant trajectory: perspectives of siblings of bone marrow transplant recipients. Cancer Nurs 30(5):E29–E34. https://doi.org/10.1097/01.NCC.0000290811.06948.2c
Willard VW, Leung W, Huang Q et al (2014) Cognitive outcome after pediatric stem-cell transplantation: impact of age and Total-body irradiation. J Clin Oncol 32(35):3982–3989
Wolfe J, Klar N, Grier HE et al (2000) Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA 284(19):2469–2475
van der Zouwen B, Kruisselbrink AB, Jordanova ES et al (2012) Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivity. Biol Blood Marrow Transplant 18(9):1353–1367. https://doi.org/10.1016/j.bbmt.2012.06.017
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Führer, M. (2018). Palliative Care in Hematopoietic Stem Cell Transplantation. In: Wolfe, J., Jones, B., Kreicbergs, U., Jankovic, M. (eds) Palliative Care in Pediatric Oncology. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-61391-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-61391-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61390-1
Online ISBN: 978-3-319-61391-8
eBook Packages: MedicineMedicine (R0)